Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey터키 MPS, 고셔병, 폼페병 환자의 면역 및 COVID-19 상태에 대한 실제 환자 데이터Article Published on 2022-08-012022-09-12 Journal: Archives de pédiatrie : organe officiel de la Soci [Category] MERS, 변종, 유전자 메커니즘, 진단, [키워드] abnormality Autoimmunity being Course COVID-19 COVID-19 in patient COVID-19 infection cytokine Diagnosis discharged disease dysfunction enzyme ERT evaluate Gaucher Gaucher Disease Hashimoto thyroiditis IgA level IgM immune dysfunction Immunity immunodeficiency immunological intensive care laboratory result Laboratory tests LSD LSDs Lymphocyte count Lysosomal storage disorder median age Mild symptom MPS mucopolysaccharidosis nine parameter pathway Patient patient data patients who survived Pompe. positive problem pulmonary involvement receiving reducing reported Secondary bacterial infections social contact subgroup the patient therapy Turkey type I type III [DOI] 10.1016/j.arcped.2022.05.003 PMC 바로가기 [Article Type] Article
No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort studyArticle Published on 2022-03-012023-07-07 Journal: Internal medicine journal [Category] COVID19(2023년), [키워드] coronavirus COVID-19 Gaucher Mortality national. SARS-CoV-2 [DOI] 10.1111/imj.15673 PMC 바로가기